Results 111 to 120 of about 14,720 (176)

Integrative clinicogenomic analysis of the monoallelic pathogenic substitution p.Thr228Met in the GCK gene as a nosological marker of type 3 diabetes (MODY 2) with a phenotype of moderate stable hyperglycemia and preserved β-cell secretory capacity

Клинический разбор в общей медицине
Monogenic forms of diabetes mellitus, collectively classified as MODY (Maturity Onset Diabetes of the Young), represent rare, genetically determined variants of the disease with an autosomal dominant inheritance pattern, typically manifesting at a young ...
Svyatoslav M. Yurin, Dmitry A. Apalkov, Tatiana A. Minenkova, Natalia S. Razinkova, Alexandra V. Serezhkina   +4 more
doaj   +1 more source

Clinical characteristics, treatment, and treatment switch after molecular‐genetic classification in individuals with maturity‐onset diabetes of the young: Insights from the multicenter real‐world DPV registry

Journal of Diabetes
Background Individuals with maturity‐onset diabetes of the young (MODY) are often misdiagnosed as type 1 or type 2 diabetes and receive inappropriate care. We aimed to investigate the characteristics and treatment of all MODY types in a multicenter, real‐
Stefanie Lanzinger, Katharina Laubner, Katharina Warncke, Julia K. Mader, Sebastian Kummer, Claudia Boettcher, Torben Biester, Angela Galler, Daniela Klose, Reinhard W. Holl   +9 more
doaj   +1 more source

Identification of GCK-maturity-onset diabetes of the young in cases of neonatal hyperglycemia: A case series and review of clinical features. [PDF]

Pediatr Diabetes, 2021
Hughes AE, De Franco E, Globa E, Zelinska N, Hilgard D, Sifianou P, Hattersley AT, Flanagan SE.   +7 more
europepmc   +1 more source

Atypical hyperglycemia presentation suggests considering a diagnostic of other types of diabetes: first reported GCK-MODY in Perú. [PDF]

Clin Diabetes Endocrinol, 2020
Lizarzaburu-Robles JC, Gomez-de-la-Torre JC, Castro-Mujica MDC, Vento F, Villanes S, Salsavilca E, Guerin C.   +6 more
europepmc   +1 more source

¿Qué sabemos de MODY en el embarazo?

Revista de la Sociedad Argentina de Diabetes
La prevalencia de MODY se estima en al menos del 1,1% al 6,5% de la población diabética pediátrica. Los tipos GCK-MODY, HNF1A-MODY y HNF4A-MODY representan >90% de los casos MODY. Si bien algunas formas de MODY no requieren tratamiento (GCK-MODY), otros
Cristina Faingold
doaj  

Sequencing Cell-free Fetal DNA in Pregnant Women With GCK-MODY.

J Clin Endocrinol Metab, 2021
Kwak SH, Powe CE, Jang SS, Callahan MJ, Bernstein SN, Lee SM, Kang S, Park KS, Jang HC, Florez JC, Kim JI, Chae JH.   +11 more
europepmc   +1 more source

Raised blood glucose due to heterozygous glucokinase gene mutation (GCK-MODY) diagnosed for the first time in pregnancy: The dilemmas and successful management - Case report and review of literature. [PDF]

Obstet Med, 2021
Rengaraj S, Thiyagalingam S, Kathirvel V, Delhikumar CG.   +3 more
europepmc   +1 more source

Genetic testing of GCK-MODY identifies a novel pathogenic variant in a Chinese boy with early onset hyperglycemia. [PDF]

Hum Genome Var, 2020
Poon KS, Tan KM, Koay ES, Sng A.
europepmc   +1 more source

Correction to: Atypical hyperglycemia presentation suggests considering a diagnostic of other types of diabetes: first reported GCK-MODY in Perú. [PDF]

Clin Diabetes Endocrinol, 2020
Lizarzaburu-Robles JC, Gomez-de-la-Torre JC, Del Carmen Castro-Mujica M, Vento F, Villanes S, Salsavilca E, Guerin C.   +6 more
europepmc   +1 more source

Identification of a novel glucokinase mutation in an Indian woman with GCK-MODY [PDF]

The Lancet Diabetes & Endocrinology, 2016
Sujeet Jha, Samreen Siddiqui, Swati Waghdhare, Shweta Dubey, Shuba Krishna, Kalyanasundaram Subramanian, Jyoti Bajpai Dikshit, L Ravikiran, Amit Bhargava   +8 more
openaire   +1 more source